Medical News Summary: Concerns over Celebrex use mounting
About: Concerns over Celebrex use mounting
Date: 18 December 2004
Source: Health Talk
Medical News Summary (summary of medical news story as reported by Health Talk): The manufacturer of Celebrex, Pfizer, refuses to withdraw it’s product from the market despite the fact that research has shown that it can increase the risk of heart attack if taken in low doses. This side effect was recently noticed during a cancer prevention trial which was stopped suddenly when it was found that Celebrex was associated with a tripled risk of cardiovascular events when taken in large doses. Celebrex belongs to the same class of drugs as the recently banned Vioxx – Cox-2 inhibitors. In fact, the whole class of Cox-2 inhibitors is being scrutinized for their association with increased risk of cardiovascular events. Even the FDA supports the decision to leave Celebrex on the market but warns consumers to discuss alternative medications with their doctor.
URL: http://www.healthtalk.ca/celebrex_heart_stroke_12182004_6732.php
Related Disease Topics: Arthritis, Pain, Heart attack, Stroke, Cardiovascular disease, Cancer
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Medication
- medication and arthritis
- medication and pain
- medication and heart attack
- medication and stroke
- medication and cardiovascular disease
- medication and cancer
- Research
- research and arthritis
- research and pain
- research and heart attack
- research and stroke
- research and cardiovascular disease
- research and cancer
- Side effect
- Side effect and arthritis
- Side effect and pain
- Side effect and heart attack
- Side effect and stroke
- Side effect and cardiovascular disease
- Side effect and cancer
- risk and arthritis
- risk and pain
- risk and heart attack
- risk and stroke
- risk and cardiovascular disease
- risk and cancer
Medical Tools & Articles:
Next articles:
Medical Articles: